These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 6995486)

  • 41. An analysis of hepatic venocclusive disease and centrilobular hepatic degeneration following bone marrow transplantation.
    Shulman HM; McDonald GB; Matthews D; Doney KC; Kopecky KJ; Gauvreau JM; Thomas ED
    Gastroenterology; 1980 Dec; 79(6):1178-91. PubMed ID: 7002704
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Vanishing bile duct syndrome following allogeneic bone marrow transplantation].
    Aliani S; Meyer S; Krenn T; Müller-Molaian I; Graf N
    Klin Padiatr; 2002; 214(6):371-4. PubMed ID: 12424687
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Fatal veno-occlusive disease of the liver following high dose chemotherapy, irradiation and bone marrow transplantation.
    Woods WG; Dehner LP; Nesbit ME; Krivit W; Coccia PF; Ramsay NK; Kim TH; Kersey JH
    Am J Med; 1980 Feb; 68(2):285-90. PubMed ID: 6986767
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The diagnostic accuracy of the rectal biopsy in acute graft-versus-host disease: a prospective study of thirteen patients.
    Epstein RJ; McDonald GB; Sale GE; Shulman HM; Thomas ED
    Gastroenterology; 1980 Apr; 78(4):764-71. PubMed ID: 6986319
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Bile duct paucity ("intrahepatic atresia").
    Witzleben CL
    Perspect Pediatr Pathol; 1982; 7():185-201. PubMed ID: 6981794
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Suppression of graft-versus-host disease and amplification of graft-versus-tumor effects by activated natural killer cells after allogeneic bone marrow transplantation.
    Asai O; Longo DL; Tian ZG; Hornung RL; Taub DD; Ruscetti FW; Murphy WJ
    J Clin Invest; 1998 May; 101(9):1835-42. PubMed ID: 9576746
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Xanthomatous Cells in Cutaneous Graft-Versus-Host Disease Biopsies: A Clue for the Diagnosis of Hepatic Graft-Versus-Host Disease.
    Gamé D; López L; Román C; Santos-Briz Á
    Am J Dermatopathol; 2018 Oct; 40(10):754-757. PubMed ID: 29570132
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The skin biopsy in the diagnosis of acute graft-versus-host disease in man.
    Sale GE; Lerner KG; Barker EA; Shulman HM; Thomas ED
    Am J Pathol; 1977 Dec; 89(3):621-36. PubMed ID: 23008
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Histological features of skin and rectal biopsy specimens after autologous and allogeneic bone marrow transplantation.
    Sviland L; Pearson AD; Eastham EJ; Hamilton PJ; Proctor SJ; Malcolm AJ
    J Clin Pathol; 1988 Feb; 41(2):148-54. PubMed ID: 3280605
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Acute graft-versus-host disease after allogeneic bone marrow transplantation.
    Perreault C; Gyger M; Boileau J; Bonny Y; Cousineau S; Lacombe M; Lavallee R; Tawil E; D'Angelo G
    Can Med Assoc J; 1983 Nov; 129(9):969-74. PubMed ID: 6367917
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Similarity between hepatic graft-versus-host disease and primary biliary cirrhosis.
    Wakae T; Takatsuka H; Seto Y; Iwata N; Mori A; Okada M; Fujimori Y; Okamoto T; Kakishita E; Hara H
    Hematology; 2002 Oct; 7(5):305-10. PubMed ID: 12850818
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Significance of central perivenulitis in pediatric liver transplantation.
    Abraham SC; Freese DK; Ishitani MB; Krasinskas AM; Wu TT
    Am J Surg Pathol; 2008 Oct; 32(10):1479-88. PubMed ID: 18708942
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Pathology of the thymus after allogeneic bone marrow transplantation in man. A histologic immunohistochemical study of 36 patients.
    Müller-Hermelink HK; Sale GE; Borisch B; Storb R
    Am J Pathol; 1987 Nov; 129(2):242-56. PubMed ID: 3314529
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Long-term liver dysfunction after allogeneic bone marrow transplantation: clinical features and course in 61 patients.
    Tomás JF; Pinilla I; García-Buey ML; García A; Figuera A; Gómez-García de Soria VGG ; Moreno R; Fernández-Rañada JM
    Bone Marrow Transplant; 2000 Sep; 26(6):649-55. PubMed ID: 11035372
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Frequency, risk factors, and outcome of acute kidney injury following bone marrow transplantation at Dr Shariati Hospital in Tehran.
    Saddadi F; Najafi I; Hakemi MS; Falaknazi K; Attari F; Bahar B
    Iran J Kidney Dis; 2010 Jan; 4(1):20-6. PubMed ID: 20081300
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Analysis of acute liver "graft-versus-host disease" following allogeneic myeloablative stem cell transplant].
    Doki N; Saito Y; Hatsumi N; Irisawa H; Sakura T; Miyawaki S
    Rinsho Ketsueki; 2004 Jan; 45(1):57-60. PubMed ID: 14999935
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Venoocclusive liver disease after bone marrow transplantation: findings at duplex sonography.
    Herbetko J; Grigg AP; Buckley AR; Phillips GL
    AJR Am J Roentgenol; 1992 May; 158(5):1001-5. PubMed ID: 1566656
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Graft-versus-leukaemia activity associated with CMV-seropositive donor, post-transplant CMV infection, young donor age and chronic graft-versus-host disease in bone marrow allograft recipients. The Nordic Bone Marrow Transplantation Group.
    Jacobsen N; Badsberg JH; Lönnqvist B; Ringdén O; Volin L; Rajantie J; Nikoskelainen J; Keiding N
    Bone Marrow Transplant; 1990 Jun; 5(6):413-8. PubMed ID: 2164434
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Fontan-associated liver disease: Spectrum of US findings.
    Bae JM; Jeon TY; Kim JS; Kim S; Hwang SM; Yoo SY; Kim JH
    Eur J Radiol; 2016 Apr; 85(4):850-6. PubMed ID: 26971434
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Distinct patterns of minimal residual disease associated with graft-versus-host disease after allogeneic bone marrow transplantation for chronic myelogenous leukemia.
    Pichert G; Roy DC; Gonin R; Alyea EP; Bélanger R; Gyger M; Perreault C; Bonny Y; Lerra I; Murray C
    J Clin Oncol; 1995 Jul; 13(7):1704-13. PubMed ID: 7602361
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.